{
    "name": "mupirocin",
    "comment": "Rx",
    "other_names": [
        "Bactroban",
        "Bactroban Nasal",
        "Centany"
    ],
    "classes": [
        "Antibacterials",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/bactroban-nasal-mupirocin-topical-343473",
    "pregnancy": {
        "common": [
            "There are insufficient human data to establish whether there is drug-associated risk with therapy in pregnant women; systemic absorption of mupirocin through intact human skin is minimal following topical administration of mupirocin ointment; no developmental toxicity was observed in rats or rabbits treated with mupirocin subcutaneously during organogenesis at doses of 160 or 40 mg per kg per day, respectively (22 and 11 times the human topical dose based on calculations of dose divided by the entire body surface area)"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Not known whether mupirocin is present in human milk, has effects on breastfed child, or has effects on milk production; however, breastfeeding is not expected to result in exposure of child to drug due to minimal systemic absorption following topical administration; developmental and health benefits of breastfeeding should be considered along with motherâ€™s clinical need for therapy and any potential adverse effects on breastfed child from therapy or from underlying maternal condition",
            "To minimize oral exposure of drug to children, a breast and/or nipple being treated with mupirocin ointment should be thoroughly washed prior to breastfeeding"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Anaphylaxis, urticaria, angioedema, and generalized rash reported",
                "Manufacturer cautions against use of mupirocin ointment in burn patients, particularly those with extensive burns, since potentially toxic amounts of polyethylene glycol (PEG) contained in the vehicle may be absorbed percutaneously",
                "Avoid contact with eyes; in case of accidental contact, rinse well with water",
                "Discontinue use in event of sensitization or severe local irritation from ointment",
                "Clostridium difficile-associated diarrhea (CDAD) reported with use; if CDAD suspected or confirmed, discontinue ongoing antibacterial drug use not directed against C. difficile; institute appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation, as clinically indicated",
                "Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi",
                "Not formulated for use on mucosal surfaces; intranasal use has been associated with isolated reports of stinging and drying",
                "Not for use in conditions where absorption of large quantities of polyethylene glycol possible, especially if there is evidence of moderate or severe renal impairment; polyethylene glycol can be absorbed from open wounds and damaged skin and is excreted by the kidneys",
                "Ointment should not be used with intravenous cannulae or at central intravenous sites because of the potential to promote fungal infections and antimicrobial resistance"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Headache",
            "percent": "1.7"
        },
        {
            "name": "Nausea",
            "percent": "1.7"
        },
        {
            "name": "Burning",
            "percent": "1-3"
        },
        {
            "name": "Stinging",
            "percent": "1-3"
        },
        {
            "name": "Pain",
            "percent": "1-3"
        },
        {
            "name": "Pruritus",
            "percent": "1-3"
        },
        {
            "name": "Rash",
            "percent": "1-3"
        },
        {
            "name": "Cellulitis",
            "percent": "1"
        },
        {
            "name": "Dry skin",
            "percent": "1"
        },
        {
            "name": "Erythema",
            "percent": "1"
        },
        {
            "name": "Incr exudate",
            "percent": "1"
        },
        {
            "name": "Pain or bleeding secondary to eczema",
            "percent": "1"
        },
        {
            "name": "Secondary wound infection",
            "percent": "1"
        },
        {
            "name": "Swelling",
            "percent": "1"
        },
        {
            "name": "Tenderness",
            "percent": "1"
        },
        {
            "name": "Urticaria",
            "percent": "1"
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Ulcerative stomatitis",
            "percent": null
        }
    ]
}